Rising Cost Of PrEP, A Pill That Prevents HIV, Pushes It Out Of Reach For Many - News Channel One

Breaking News

Rising Cost Of PrEP, A Pill That Prevents HIV, Pushes It Out Of Reach For Many

7/01/2018 , , , , , , , , ,
Gilead Sciences makes Truvada, a medicine known generically as "pre-exposure prophylaxis," or PrEP. Consistent, daily doses of the drug are thought to reduce the risk of getting HIV from sex by more than 90 percent.

Many people at high risk for HIV can't afford PrEP, though it's more than 90 percent effective if taken daily. Its list price, close to $2,000 for a 30-day supply, has risen 45 percent in six years.

(Image credit: Paul Sakuma/AP)



from News : NPR https://ift.tt/2tEMBTw

No comments

Subscribe to: Post Comments ( Atom )